$VRUS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pharmasset Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pharmasset Inc. Get notifications about new insider transactions in Pharmasset Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.15 | 1,755 | 33,601 | 4,434 | 6.2 K to 4.4 K (-28.36 %) |
Jun 09 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.15 | 8,328 | 159,448 | 21,041 | 29.4 K to 21 K (-28.36 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Option Exercise | M | 3.00 | 77,498 | 232,494 | 5,835 | |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Option Exercise | M | 6.00 | 3,766 | 22,596 | 0 | |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 18.09 | 100 | 1,809 | 19,500 | 19.6 K to 19.5 K (-0.51 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 18.06 | 100 | 1,806 | 19,600 | 19.7 K to 19.6 K (-0.51 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 18.00 | 500 | 9,000 | 19,700 | 20.2 K to 19.7 K (-2.48 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.81 | 100 | 1,781 | 20,200 | 20.3 K to 20.2 K (-0.49 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.80 | 1,061 | 18,886 | 20,300 | 21.4 K to 20.3 K (-4.97 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.62 | 100 | 1,762 | 21,461 | 21.6 K to 21.5 K (-0.46 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.63 | 100 | 1,763 | 21,361 | 21.5 K to 21.4 K (-0.47 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.59 | 100 | 1,759 | 21,661 | 21.8 K to 21.7 K (-0.46 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.59 | 100 | 1,759 | 21,661 | 21.8 K to 21.7 K (-0.46 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.58 | 200 | 3,516 | 21,761 | 22 K to 21.8 K (-0.91 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.57 | 1,100 | 19,327 | 21,961 | 23.1 K to 22 K (-4.77 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.56 | 100 | 1,756 | 23,061 | 23.2 K to 23.1 K (-0.43 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.55 | 200 | 3,510 | 23,161 | 23.4 K to 23.2 K (-0.86 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.54 | 1,000 | 17,540 | 23,361 | 24.4 K to 23.4 K (-4.10 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.53 | 500 | 8,765 | 24,361 | 24.9 K to 24.4 K (-2.01 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.52 | 600 | 10,512 | 24,861 | 25.5 K to 24.9 K (-2.36 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.51 | 500 | 8,755 | 25,461 | 26 K to 25.5 K (-1.93 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 17.50 | 74,803 | 1,309,053 | 25,961 | 100.8 K to 26 K (-74.24 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Buy | M | 3.00 | 77,498 | 232,494 | 100,761 | 23.3 K to 100.8 K (+333.14 %) |
May 29 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Buy | M | 6.00 | 3,766 | 22,596 | 23,266 | 19.5 K to 23.3 K (+19.31 %) |
May 21 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 4.20 | 20,833 | 87,499 | 62,500 | |
May 21 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Sell | S | 18.00 | 20,833 | 374,994 | 0 | 20.8 K to 0 (-100.00 %) |
May 21 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 4.20 | 20,833 | 87,499 | 20,833 | 0 to 20.8 K |
Apr 08 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Option Exercise | M | 6.00 | 100 | 600 | 3,766 | |
Apr 08 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Option Exercise | M | 6.00 | 400 | 2,400 | 3,866 | |
Apr 08 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.00 | 100 | 2,000 | 19,500 | 19.6 K to 19.5 K (-0.51 %) |
Apr 08 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Buy | M | 6.00 | 100 | 600 | 19,600 | 19.5 K to 19.6 K (+0.51 %) |
Apr 08 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.00 | 400 | 8,000 | 19,500 | 19.9 K to 19.5 K (-2.01 %) |
Apr 08 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Buy | M | 6.00 | 400 | 2,400 | 19,900 | 19.5 K to 19.9 K (+2.05 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Option Exercise | M | 6.00 | 734 | 4,404 | 4,266 | |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Option Exercise | M | 2.55 | 37,166 | 94,773 | 0 | |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.05 | 800 | 16,040 | 19,500 | 20.3 K to 19.5 K (-3.94 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.03 | 700 | 14,021 | 20,300 | 21 K to 20.3 K (-3.33 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.02 | 300 | 6,006 | 21,000 | 21.3 K to 21 K (-1.41 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.01 | 900 | 18,009 | 21,300 | 22.2 K to 21.3 K (-4.05 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Sell | S | 20.00 | 35,200 | 704,000 | 22,200 | 57.4 K to 22.2 K (-61.32 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Buy | M | 6.00 | 734 | 4,404 | 57,400 | 56.7 K to 57.4 K (+1.30 %) |
Apr 04 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Buy | M | 2.55 | 37,166 | 94,773 | 56,666 | 19.5 K to 56.7 K (+190.59 %) |
Apr 02 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Sell | S | 20.00 | 43 | 860 | 0 | 43 to 0 (-100.00 %) |
Apr 02 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Sell | S | 20.00 | 5,074 | 101,480 | 0 | 5.1 K to 0 (-100.00 %) |
Apr 02 2008 | VRUS | Pharmasset Inc | HENNER DENNIS | 10% Owner | Sell | S | 20.00 | 745 | 14,901 | 0 | 745 to 0 (-100.00 %) |
Apr 02 2008 | VRUS | Pharmasset Inc | HENNER DENNIS | 10% Owner | Sell | S | 20.00 | 4,645 | 92,904 | 0 | 4.6 K to 0 (-100.00 %) |
Mar 27 2008 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | A | 17.55 | 40,000 | 702,000 | 40,000 | |
Mar 14 2008 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Executive VP & CFO | Buy | P | 16.32 | 1,000 | 16,320 | 207,250 | 206.3 K to 207.3 K (+0.48 %) |
Mar 14 2008 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Executive VP & CFO | Buy | P | 15.60 | 4,000 | 62,400 | 206,250 | 202.3 K to 206.3 K (+1.98 %) |
Mar 04 2008 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | M | 3.00 | 26,667 | 80,001 | 0 | |
Mar 04 2008 | VRUS | Pharmasset Inc | Carney William J | Director | Buy | M | 3.00 | 26,667 | 80,001 | 57,166 | 30.5 K to 57.2 K (+87.44 %) |
Feb 22 2008 | VRUS | Pharmasset Inc | GALAKATOS NICHOLAS | 10% Owner | Sell | S | 17.54 | 304 | 5,332 | 0 | 304 to 0 (-100.00 %) |
Feb 22 2008 | VRUS | Pharmasset Inc | GALAKATOS NICHOLAS | 10% Owner | Sell | S | 17.54 | 10,632 | 186,485 | 0 | 10.6 K to 0 (-100.00 %) |
Feb 11 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 21.36 | 6,874 | 146,829 | 4,061 | 10.9 K to 4.1 K (-62.86 %) |
Feb 11 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 23.02 | 17,450 | 401,699 | 1,231,339 | 1.2 M to 1.2 M (-1.40 %) |
Feb 11 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Sell | S | 21.36 | 6,874 | 146,829 | 4,061 | 10.9 K to 4.1 K (-62.86 %) |
Feb 11 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Sell | S | 23.02 | 17,450 | 401,699 | 1,231,339 | 1.2 M to 1.2 M (-1.40 %) |
Feb 11 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 21.36 | 27,925 | 596,478 | 0 | 27.9 K to 0 (-100.00 %) |
Feb 11 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 23.02 | 36,664 | 844,005 | 2,587,168 | 2.6 M to 2.6 M (-1.40 %) |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | J | 0.00 | 68,295 | 0 | 68,295 | 0 to 68.3 K |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | J | 0.00 | 10,935 | 0 | 10,935 | 0 to 10.9 K |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | J | 0.00 | 5,117 | 0 | 5,117 | 0 to 5.1 K |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | J | 0.00 | 5,390 | 0 | 5,390 | 0 to 5.4 K |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | J | 0.00 | 10,936 | 0 | 10,936 | 0 to 10.9 K |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 23.86 | 12,993 | 310,013 | 1,248,789 | 1.3 M to 1.2 M (-1.03 %) |
Feb 06 2008 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Sell | J | 0.00 | 713,912 | 0 | 1,261,782 | 2 M to 1.3 M (-36.13 %) |
Feb 06 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | J | 0.00 | 35,558 | 0 | 35,558 | 0 to 35.6 K |
Feb 06 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | J | 0.00 | 27,925 | 0 | 27,925 | 0 to 27.9 K |
Feb 06 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | J | 0.00 | 57,353 | 0 | 57,353 | 0 to 57.4 K |
Feb 06 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 23.86 | 27,300 | 651,378 | 2,623,832 | 2.7 M to 2.6 M (-1.03 %) |
Feb 06 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 2,651,132 | 4.2 M to 2.7 M (-36.13 %) |
Jan 18 2008 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | A | 13.67 | 10,000 | 136,700 | 10,000 | |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | J | 0.00 | 68,295 | 0 | 68,295 | 0 to 68.3 K |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | J | 0.00 | 10,935 | 0 | 10,935 | 0 to 10.9 K |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | J | 0.00 | 5,117 | 0 | 5,117 | 0 to 5.1 K |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | J | 0.00 | 5,390 | 0 | 5,390 | 0 to 5.4 K |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | J | 0.00 | 10,936 | 0 | 10,936 | 0 to 10.9 K |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Sell | S | 23.86 | 12,993 | 310,013 | 1,248,789 | 1.3 M to 1.2 M (-1.03 %) |
Feb 06 2008 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Sell | J | 0.00 | 713,912 | 0 | 1,261,782 | 2 M to 1.3 M (-36.13 %) |
Jan 18 2008 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | A | 13.67 | 10,000 | 136,700 | 10,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | Price P Schaefer | President and CEO | Option Exercise | A | 13.67 | 93,000 | 1,271,310 | 93,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | A | 13.67 | 10,000 | 136,700 | 10,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Option Exercise | A | 13.67 | 20,000 | 273,400 | 20,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Chief Financial Off ... | Option Exercise | A | 13.67 | 31,000 | 423,770 | 31,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | A | 13.67 | 25,000 | 341,750 | 25,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | A | 13.67 | 10,000 | 136,700 | 10,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | A | 13.67 | 10,000 | 136,700 | 10,000 | |
Jan 18 2008 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | A | 13.67 | 10,000 | 136,700 | 10,000 | |
Nov 08 2007 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | A | 13.88 | 75,000 | 1,041,000 | 75,000 | |
Sep 17 2007 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Option Exercise | M | 3.00 | 10,000 | 30,000 | 83,333 | |
Sep 17 2007 | VRUS | Pharmasset Inc | OTTO MICHAEL | Exec.VP,Pharm.Resea ... | Buy | M | 3.00 | 10,000 | 30,000 | 19,500 | 9.5 K to 19.5 K (+105.26 %) |
Aug 13 2007 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Executive VP & CFO | Option Exercise | M | 3.00 | 20,833 | 62,499 | 63,000 | |
Aug 13 2007 | VRUS | Pharmasset Inc | LEUTZINGER KURT | Executive VP & CFO | Buy | M | 3.00 | 20,833 | 62,499 | 202,250 | 181.4 K to 202.3 K (+11.48 %) |
May 04 2007 | VRUS | Pharmasset Inc | Price P Schaefer | President & CEO | Option Exercise | A | 9.00 | 66,667 | 600,003 | 66,667 | |
May 04 2007 | VRUS | Pharmasset Inc | Schinazi Raymond F | 10% Owner | Option Exercise | C | 0.00 | 369,179 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | Schinazi Raymond F | 10% Owner | Buy | C | 0.00 | 246,119 | 0 | 1,289,156 | 1 M to 1.3 M (+23.60 %) |
May 04 2007 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | X | 0.15 | 323,542 | 48,531 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | C | 0.00 | 582,375 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Buy | P | 9.00 | 222,222 | 1,999,998 | 1,872,285 | 1.7 M to 1.9 M (+13.47 %) |
May 04 2007 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Buy | X | 0.15 | 212,099 | 31,815 | 1,650,063 | 1.4 M to 1.7 M (+14.75 %) |
May 04 2007 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Buy | C | 0.00 | 388,250 | 0 | 1,437,964 | 1 M to 1.4 M (+36.99 %) |
May 04 2007 | VRUS | Pharmasset Inc | Burrill & CO (Life Sciences GP ... | 10% Owner | Option Exercise | X | 0.15 | 323,542 | 48,531 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | Burrill & CO (Life Sciences GP ... | 10% Owner | Option Exercise | C | 0.00 | 582,375 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | Burrill & CO (Life Sciences GP ... | 10% Owner | Buy | P | 9.00 | 222,222 | 1,999,998 | 1,872,285 | 1.7 M to 1.9 M (+13.47 %) |
May 04 2007 | VRUS | Pharmasset Inc | Burrill & CO (Life Sciences GP ... | 10% Owner | Buy | X | 0.15 | 212,099 | 31,815 | 1,650,063 | 1.4 M to 1.7 M (+14.75 %) |
May 04 2007 | VRUS | Pharmasset Inc | Burrill & CO (Life Sciences GP ... | 10% Owner | Buy | C | 0.00 | 388,250 | 0 | 1,437,964 | 1 M to 1.4 M (+36.99 %) |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 1,076,231 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 367,999 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Option Exercise | X | 0.10 | 382,365 | 38,237 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Buy | P | 9.00 | 277,777 | 2,499,993 | 4,094,500 | 3.8 M to 4.1 M (+7.28 %) |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Buy | C | 0.00 | 717,487 | 0 | 3,816,723 | 3.1 M to 3.8 M (+23.15 %) |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Buy | C | 0.00 | 245,331 | 0 | 3,099,236 | 2.9 M to 3.1 M (+8.60 %) |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Payment of Exercise | F | 9.00 | 4,245 | 38,205 | 2,853,905 | 2.9 M to 2.9 M (-0.15 %) |
May 04 2007 | VRUS | Pharmasset Inc | GADICKE ANSBERT | Director | Buy | X | 0.15 | 254,906 | 38,236 | 2,858,150 | 2.6 M to 2.9 M (+9.79 %) |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Option Exercise | C | 0.00 | 1,076,231 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Option Exercise | C | 0.00 | 367,999 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Option Exercise | X | 0.10 | 382,365 | 38,237 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | P | 9.00 | 277,777 | 2,499,993 | 4,094,500 | 3.8 M to 4.1 M (+7.28 %) |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | C | 0.00 | 717,487 | 0 | 3,816,723 | 3.1 M to 3.8 M (+23.15 %) |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | C | 0.00 | 245,331 | 0 | 3,099,236 | 2.9 M to 3.1 M (+8.60 %) |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Payment of Exercise | F | 9.00 | 4,245 | 38,205 | 2,853,905 | 2.9 M to 2.9 M (-0.15 %) |
May 04 2007 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Buy | X | 0.15 | 254,906 | 38,236 | 2,858,150 | 2.6 M to 2.9 M (+9.79 %) |
May 04 2007 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Option Exercise | C | 0.00 | 910,628 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Option Exercise | X | 0.10 | 323,529 | 32,353 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | P | 9.00 | 277,777 | 2,499,993 | 1,927,774 | 1.6 M to 1.9 M (+16.84 %) |
May 04 2007 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | C | 0.00 | 607,085 | 0 | 1,649,997 | 1 M to 1.6 M (+58.21 %) |
May 04 2007 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Payment of Exercise | F | 9.00 | 3,592 | 32,328 | 1,042,912 | 1 M to 1 M (-0.34 %) |
May 04 2007 | VRUS | Pharmasset Inc | MPM BIOVENTURES III QP LP | 10% Owner | Buy | X | 0.15 | 215,683 | 32,352 | 1,046,504 | 830.8 K to 1 M (+25.96 %) |
May 04 2007 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Option Exercise | C | 0.00 | 910,628 | 0 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Option Exercise | X | 0.10 | 323,529 | 32,353 | 0 | |
May 04 2007 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | P | 9.00 | 277,777 | 2,499,993 | 1,927,774 | 1.6 M to 1.9 M (+16.84 %) |
May 04 2007 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | C | 0.00 | 607,085 | 0 | 1,649,997 | 1 M to 1.6 M (+58.21 %) |
May 04 2007 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Payment of Exercise | F | 9.00 | 3,592 | 32,328 | 1,042,912 | 1 M to 1 M (-0.34 %) |
May 04 2007 | VRUS | Pharmasset Inc | SIMON NICHOLAS J III | 10% Owner | Buy | X | 0.15 | 215,683 | 32,352 | 1,046,504 | 830.8 K to 1 M (+25.96 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | X | 0.10 | 98,043 | 9,804 | 0 | |
May 01 2007 | VRUS | Pharmasset Inc | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 176,476 | 0 | 0 | |
May 01 2007 | VRUS | Pharmasset Inc | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | P | 9.00 | 111,111 | 999,999 | 861,134 | 750 K to 861.1 K (+14.81 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Payment of Exercise | F | 9.00 | 1,635 | 14,715 | 750,023 | 751.7 K to 750 K (-0.22 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | X | 0.10 | 98,043 | 9,804 | 751,658 | 653.6 K to 751.7 K (+15.00 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 176,476 | 0 | 653,615 | 477.1 K to 653.6 K (+36.99 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM IV GMBH & CO KG | 10% Owner | Option Exercise | X | 0.10 | 52,302 | 5,230 | 0 | |
May 01 2007 | VRUS | Pharmasset Inc | TVM IV GMBH & CO KG | 10% Owner | Option Exercise | C | 0.00 | 250,121 | 0 | 0 | |
May 01 2007 | VRUS | Pharmasset Inc | TVM IV GMBH & CO KG | 10% Owner | Payment of Exercise | F | 9.00 | 872 | 7,848 | 977,802 | 978.7 K to 977.8 K (-0.09 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM IV GMBH & CO KG | 10% Owner | Buy | X | 0.10 | 52,302 | 5,230 | 978,674 | 926.4 K to 978.7 K (+5.65 %) |
May 01 2007 | VRUS | Pharmasset Inc | TVM IV GMBH & CO KG | 10% Owner | Buy | C | 0.00 | 250,121 | 0 | 926,372 | 676.3 K to 926.4 K (+36.99 %) |